You are here: Industry Insights > Cannabis

News List

GW Pharmaceuticals launches cannabis-based drug Epidiolex in US pharmaceutical-technology
November 06, 2018
UK-based GW Pharmaceuticals and its US division Greenwich Biosciences have launched an oral solution of cannabis-based drug Epidiolex in the US to treat seizures in Lennox-Gastaut syndrome (LGS) or Dravet syndrome patients aged two years and above.
Growth of medical cannabis market after approvals and clinical trials europeanpharmaceuticalreview
October 19, 2018
A report has suggested that growth of medical cannabis will reach between $11.9 and $17.1 billion by 2020, and is currently around $5 to $6 billion…
Latin America’s medical cannabis market to reach $8.5bn by 2028 pharmaceutical-technology
October 11, 2018
Research consultancy Prohibition Partners has predicted that medical cannabis will account for approximately two-thirds of the total value of Latin America’s cannabis market by 2028 in its first Latin America cannabis report.
Israel's Together Pharma to buy 50 percent stake of German cannabis biospectrumasia
September 03, 2018
Together Pharma, which produces medical cannabis had signed a deal to buy a controlling 50.01 percent stake in an unnamed German company, which is one of its customers, for 2 million euros.
Cannabis extract helps reset brain function in psychosis worldpharmanews
August 30, 2018
Research from King's College London has found that a single dose of the cannabis extract cannabidiol can help reduce brain function abnormalities seen in people with psychosis.
UK drug advisors recommend rescheduling of medical cannabis pharmatimes
July 23, 2018
Clinicians in the UK should have the option to prescribe cannabis-derived medicinal products where appropriate, drug experts have concluded, paving the way for laws prohibiting their use to be relaxed.
Singapore, with strict drug laws, to develop synthetic marijuana compounds biospectrumasia
May 02, 2018
Singapore is funding research on medical treatments containing synthetically-derived compounds of the marijuana plant
First-in-Human trial of cannabis-based therapy for Parkinson’s initiated europeanpharmaceuticalreview
April 13, 2018
GB Sciences, Inc. is planning to file an Exploratory IND and perform a Phase 0 Clinical Trial to gather valuable First-In-Human data on its proprietary cannabis-based therapies…
CBD may help curb frequency of epileptic seizures europeanpharmaceuticalreview
March 09, 2018
A naturally occurring compound found in cannabis may help to curb the frequency of epileptic seizures…
Legal Cannabis and CBD Sales are on the Rise biospace
March 05, 2018
Based on data provided by Arcview Market Research, legal cannabis sales in North America totaled $6.7 billion in 2016 and are projected to grow at a compound annual growth rate of 25 percent to an estimated $20.2 billion by 2021.

Previous page 1 2 3 4 5 6 Next page